116 related articles for article (PubMed ID: 11429786)
1. Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis.
Wang D; Russell J; Xu H; Johnson DG
Mol Carcinog; 2001 Jun; 31(2):90-100. PubMed ID: 11429786
[TBL] [Abstract][Full Text] [Related]
2. Myc lacks E2F1's ability to suppress skin carcinogenesis.
Rounbehler RJ; Schneider-Broussard R; Conti CJ; Johnson DG
Oncogene; 2001 Aug; 20(38):5341-9. PubMed ID: 11536046
[TBL] [Abstract][Full Text] [Related]
3. E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo.
Wang D; Russell JL; Johnson DG
Mol Cell Biol; 2000 May; 20(10):3417-24. PubMed ID: 10779331
[TBL] [Abstract][Full Text] [Related]
4. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development.
Pierce AM; Fisher SM; Conti CJ; Johnson DG
Oncogene; 1998 Mar; 16(10):1267-76. PubMed ID: 9546428
[TBL] [Abstract][Full Text] [Related]
5. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53.
Pierce AM; Gimenez-Conti IB; Schneider-Broussard R; Martinez LA; Conti CJ; Johnson DG
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8858-63. PubMed ID: 9671769
[TBL] [Abstract][Full Text] [Related]
6. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2.
Chen Q; Hung FC; Fromm L; Overbeek PA
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4223-31. PubMed ID: 11095619
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
8. The role of the transcription factor DP in apoptosis.
Hitchens MR; Robbins PD
Apoptosis; 2003 Oct; 8(5):461-8. PubMed ID: 12975577
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of E2F transcription factors in chemically induced mouse skin tumors.
Balasubramanian S; Ahmad N; Mukhtar H
Int J Oncol; 1999 Aug; 15(2):387-90. PubMed ID: 10402252
[TBL] [Abstract][Full Text] [Related]
10. E2F as a regulator of keratinocyte proliferation: implications for skin tumor development.
Jones SJ; Dicker AJ; Dahler AL; Saunders NA
J Invest Dermatol; 1997 Aug; 109(2):187-93. PubMed ID: 9242506
[TBL] [Abstract][Full Text] [Related]
11. E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model.
Paulson QX; McArthur MJ; Johnson DG
Cell Cycle; 2006 Jan; 5(2):184-90. PubMed ID: 16340309
[TBL] [Abstract][Full Text] [Related]
12. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
13. A new component of the transcription factor DRTF1/E2F.
Girling R; Partridge JF; Bandara LR; Burden N; Totty NF; Hsuan JJ; La Thangue NB
Nature; 1993 Mar; 362(6415):83-7. PubMed ID: 8446173
[TBL] [Abstract][Full Text] [Related]
14. The TFDP1 gene coding for DP1, the heterodimeric partner of the transcription factor E2F, is a target of deregulated E2F.
Nakajima R; Deguchi R; Komori H; Zhao L; Zhou Y; Shirasawa M; Angelina A; Goto Y; Tohjo F; Nakahashi K; Nakata K; Iwanaga R; Bradford AP; Araki K; Warita T; Ohtani K
Biochem Biophys Res Commun; 2023 Jun; 663():154-162. PubMed ID: 37141667
[TBL] [Abstract][Full Text] [Related]
15. Horizontal basal cell proliferation in the olfactory epithelium of transforming growth factor-alpha transgenic mice.
Getchell TV; Narla RK; Little S; Hyde JF; Getchell ML
Cell Tissue Res; 2000 Feb; 299(2):185-92. PubMed ID: 10741459
[TBL] [Abstract][Full Text] [Related]
16. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
Halaban R; Cheng E; Smicun Y; Germino J
J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
[TBL] [Abstract][Full Text] [Related]
17. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model.
Pierce AM; Schneider-Broussard R; Gimenez-Conti IB; Russell JL; Conti CJ; Johnson DG
Mol Cell Biol; 1999 Sep; 19(9):6408-14. PubMed ID: 10454586
[TBL] [Abstract][Full Text] [Related]
18. The DP-1 transcription factor is required for keratinocyte growth and epidermal stratification.
Chang WY; Bryce DM; D'Souza SJ; Dagnino L
J Biol Chem; 2004 Dec; 279(49):51343-53. PubMed ID: 15448153
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of novel E2F decoy oligodeoxynucleotides on mesangial cell proliferation by coexpression of E2F/DP.
Park KK; Deok Ahn J; Lee IK; Magae J; Heintz NH; Kwak JY; Lee YC; Cho YS; Kim HC; Chae YM; Ho Kim Y; Kim CH; Chang YC
Biochem Biophys Res Commun; 2003 Sep; 308(4):689-97. PubMed ID: 12927774
[TBL] [Abstract][Full Text] [Related]
20. Differential activities of E2F family members: unique functions in regulating transcription.
Pierce AM; Schneider-Broussard R; Philhower JL; Johnson DG
Mol Carcinog; 1998 Jul; 22(3):190-8. PubMed ID: 9688145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
